Roth Capital Downgrades INVO Bioscience Inc. (invo) to Neutral
Tweet
Share
E-mailGet Alerts invo Hot Sheet
Price: $0.83 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
Roth Capital analyst Scott Henry downgraded INVO Bioscience Inc. (NASDAQ: invo) from Buy to Neutral with a price target of $2.00 (from $4.00).
For an analyst ratings summary and ratings history on INVO Bioscience Inc. click here. For more ratings news on INVO Bioscience Inc. click here.
Shares of INVO Bioscience Inc. closed at $2.14 yesterday.
You May Also Be Interested In
- Hyperion DeFi, Inc. (HYPD) PT Raised to $7.10 at Cantor Fitzgerald
- Wolverine World Wide (WWW) PT Raised to $24 at Needham
- Freedom Broker Downgrades Holley (HLLY) to Hold
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
